BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21035044)

  • 1. Role of imaging in the preoperative staging of small bowel neuroendocrine tumors.
    Chambers AJ; Pasieka JL; Dixon E; Rorstad O
    J Am Coll Surg; 2010 Nov; 211(5):620-7. PubMed ID: 21035044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Staging in Patients with Small Intestinal Neuroendocrine Tumours.
    Clift AK; Faiz O; Al-Nahhas A; Bockisch A; Liedke MO; Schloericke E; Wasan H; Martin J; Ziprin P; Moorthy K; Frilling A
    J Gastrointest Surg; 2016 Jan; 20(1):180-8; discussion 188. PubMed ID: 26394880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of cytoreductive operations for peritoneal carcinomatosis with or without liver cytoreduction in patients with small bowel neuroendocrine tumors.
    Wonn SM; Limbach KE; Pommier SJ; Ratzlaff AN; Leon EJ; McCully BH; Pommier RF
    Surgery; 2021 Jan; 169(1):168-174. PubMed ID: 32473829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.
    Chambers AJ; Pasieka JL; Dixon E; Rorstad O
    Surgery; 2008 Oct; 144(4):645-51; discussion 651-3. PubMed ID: 18847650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignant tumors of the small intestine. Diagnostic problems and differentiated surgical therapy].
    Broll R; Bruch HP; Daniel D; Schiedeck T
    Chirurg; 1994 May; 65(5):451-6. PubMed ID: 8050300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical Treatment of Small Bowel Neuroendocrine Tumors.
    Farley HA; Pommier RF
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):49-61. PubMed ID: 26614368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.
    Pasquer A; Walter T; Hervieu V; Forestier J; Scoazec JY; Lombard-Bohas C; Poncet G
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S742-9. PubMed ID: 26014153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms].
    Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY
    Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASO Author Reflections: Lymphatic Metastasis of Small Bowel Neuroendocrine Tumors.
    Chen L; Chen M; Chen J
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):555-556. PubMed ID: 30600406
    [No Abstract]   [Full Text] [Related]  

  • 10. The Added Diagnostic Value of
    Addeo P; Poncet G; Goichot B; Leclerc L; Brigand C; Mutter D; Romain B; Namer IJ; Bachellier P; Imperiale A
    J Gastrointest Surg; 2018 Apr; 22(4):722-730. PubMed ID: 29235002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic Metastases.
    Chan DL; Dixon M; Law CHL; Koujanian S; Beyfuss KA; Singh S; Myrehaug S; Hallet J
    Ann Surg Oncol; 2018 Jun; 25(6):1768-1774. PubMed ID: 29560571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic differences in primary malignancies of the small intestine].
    Winde G; Glodny B; Berns T; Senninger N
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1417-20. PubMed ID: 9931899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indications and operative procedures for neuroendocrine liver metastases].
    Musholt TJ; Lang H
    Chirurg; 2009 Feb; 80(2):113-21. PubMed ID: 19212693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. It May Not Be Too Little or Too Late: Resecting Primary Small Bowel Neuroendocrine Tumors in the Presence of Metastatic Disease.
    Howe JR
    Ann Surg Oncol; 2020 Aug; 27(8):2583-2585. PubMed ID: 32500346
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of unknown primary tumors in patients with neuroendocrine liver metastases.
    Wang SC; Parekh JR; Zuraek MB; Venook AP; Bergsland EK; Warren RS; Nakakura EK
    Arch Surg; 2010 Mar; 145(3):276-80. PubMed ID: 20231629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposed staging system for gastrointestinal carcinoid tumors.
    Landry CS; McMasters KM; Scoggins CR; Martin RC
    Am Surg; 2008 May; 74(5):418-22. PubMed ID: 18481499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.
    Norlén O; Stålberg P; Öberg K; Eriksson J; Hedberg J; Hessman O; Janson ET; Hellman P; Åkerström G
    World J Surg; 2012 Jun; 36(6):1419-31. PubMed ID: 21984144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of tumors of the small intestine. Clinical results of 31 years/review of the literature].
    Sarkar MR; Laqua D; Bähr R
    Leber Magen Darm; 1996 Jul; 26(4):204-6, 209-14. PubMed ID: 8965603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on Surgical Management of Small Bowel Neuroendocrine Tumors.
    Moris D; Ntanasis-Stathopoulos I; Tsilimigras DI; Vagios S; Karamitros A; Karaolanis G; Griniatsos J; Papalampros A; Papaconstantinou I; Glantzounis GK; Spartalis E; Blazer DG; Felekouras E
    Anticancer Res; 2018 Mar; 38(3):1267-1278. PubMed ID: 29491050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.
    Scigliano S; Lebtahi R; Maire F; Stievenart JL; Kianmanesh R; Sauvanet A; Vullierme MP; Couvelard A; Belghiti J; Ruszniewski P; Le Guludec D
    Endocr Relat Cancer; 2009 Sep; 16(3):977-90. PubMed ID: 19470616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.